irinotecan has been researched along with Hodgkin Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benoit, LT; Cochran, JH; Emmerton, KK; Lau, UY; Senter, PD; Stevens, NS; Zaval, M | 1 |
Fujimoto, K; Kaneki, T; Koizumi, T; Kubo, K; Urushihata, K; Yamaguchi, S | 1 |
Ariyoshi, Y; Furue, H; Kimura, I; Masaoka, T; Ogawa, M; Oguro, M; Ohno, R; Saito, H; Sakai, Y; Yoshida, Y | 1 |
Eckhardt, SG | 1 |
1 trial(s) available for irinotecan and Hodgkin Disease
Article | Year |
---|---|
[An early phase II study of CPT-11 (irinotecan hydrochloride) in patients with hematological malignancies].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Diarrhea; Drug Administration Schedule; Female; Hodgkin Disease; Humans; Irinotecan; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1994 |
3 other study(ies) available for irinotecan and Hodgkin Disease
Article | Year |
---|---|
Lactone Stabilization is Not a Necessary Feature for Antibody Conjugates of Camptothecins.
Topics: Animals; Antibodies; Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Hodgkin Disease; Humans; Hydrogen-Ion Concentration; Irinotecan; Lactones; Mice; Mice, SCID; Pharmacokinetics | 2018 |
Successful salvage therapy of irinotecan for relapsed Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Agents; Camptothecin; Enzyme Inhibitors; Hodgkin Disease; Humans; Irinotecan; Male; Radiography; Recurrence; Salvage Therapy; Topoisomerase I Inhibitors | 2002 |
Irinotecan: a review of the initial phase I trials.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; France; Hodgkin Disease; Humans; Irinotecan; Japan; Leukemia; Lymphoma, Non-Hodgkin; United States | 1998 |